EpiPredict

10/10/2018

EpiPredict organises the conference ‘Systems : Towards Precision Cancer Medicine’ , 27-30 November '18! Abstract Submission until October 14th. We hope to see you in Amsterdam.

05/03/2018

Our conference is added to the SystemsMedicine.net events page!

Conference Systems Epigenetics: Towards Precision Cancer Medicine, November 2018, Amsterdam
EpiPredict

https://www.systemsmedicine.net/posts/conference-systems-epigenetics-towards-precision-cancer-medicine-november-2018-amsterdam

09/02/2018

We are honoured to announce the conference ‘Systems Epigenetics: Towards Precision Cancer Medicine’ that we organize in Amsterdam, the Netherlands, on 27-30 November 2018! www.systemsepigenetics2018.eu

06/02/2018

Watch our latest video in which Horizon2020 EpiPredict fellow Daniel Vilar Jorge from Imperial College London explains why scientists study to better understand .

https://www.youtube.com/watch?v=6x9HRuB8MmA

Video in collaboration with Science Matters - Science Communication.

Breast cancer patients with oestrogen receptor positive tumours are treated with endocrine (hormonal) therapy. However, resistance to endocrine therapy is a ...

22/12/2017

Read our blog by Maryam Soleimani Dodaran University of Amsterdam / Universiteit van Amsterdam, NL). She explains her role as data scientist in the international research effort EpiPredict. This blog published in the online publishing platform Medium was established in collaboration with EpiPredict Partner Organisation Science Matters.

Maryam Soleimani Dodaran is a PhD student within the European research consortium EpiPredict and works at the Swammerdam Institute for Life…

14/12/2017

The EpiPredict fellows are preparing for the EpiPredict Imperial College London Science Cafe, tonight at Maggie's Centres in front of Charing Cross Hospital, London, UK, 18h00-20h00, 14 December 2017, together with Kelly Gleason from ICL, Rathenau Instituut and Science Matters. Marie Skłodowska-Curie Actions

06/11/2017

'Knowledge is power: Would you share your data or keep it private?' Read our latest EpiPredict blog about via Medium https://medium.com//knowledge-is-power-aef925176644

Would you share your genome data or keep it private?

11/09/2017

'The epigenome editors: How tools such as CRISPR offer new details about epigenetics'.

EpiPredict WP leader Prof. Dr Marianne Rots (UMCG , NL) has been interviewed for the feature story in Nature Medicine

Nature Medicine

06/06/2017

"Can you control your genes??"

In our new blog we explain why DNA isn't your destiny!


https://medium.com//can-you-control-your-genes-yes-you-can-with-epigenetics-7e82bab567d5

Written by Désirée Goubert (UMCG, NL) and Stefania Astrologo (UvA, NL), together with EpiPredict Partner Organisation Biotecture.

31/01/2017

Researchers discover novel mechanism behind underlying breast cancer hormone therapy resistance. An international team of researchers, including researchers, has discovered a mechanism that makes a common type of breast cancer cells resistant to a specific form of hormone treatment. Their findings have been published online on Nature Genetics, 23 January 2017.

Nature Genetics | doi:10.1038/ng.3773

13/01/2017

Worldwide, 25% of female cancer patients are diagnosed with breast cancer. Over 20% of the patients expressing hormone receptors show treatment relapse within 10 years to endocrine therapies.

To improve and personalize the treatment for breast cancer patients, it is important to understand why some patients become resistant where others do not.

Why do cancer cells initially expressing hormone receptors, become resistant to hormone therapy?


https://medium.com//from-lab-bench-to-bed-fd41b276f9dc #.ftyq0htsu

How understanding epigenetics could benefit breast cancer patients

19/12/2016

You are kindly invited to our EpiPredict event, at DKFZ, Heidelberg, Thursday 26 January!

Please register via eventbrite: https://www.eventbrite.co.uk/e/everything-you-always-wanted-to-know-about-epigenetics-tickets-30118373867

Epigenetics, everything you always wanted to know:

-Keynote speaker: Prof. Henk Stunnenberg, Radboud University Medical Centre, NL
-Science café: a panel discussion about applying epigenetics in breast cancer treatment

Panel members:
Prof. Henk Stunnenberg (Radboud University Medical Centre, NL)
Prof. Irmgard Nippert (University of Munster, DE)
Prof. Stefan Wiemann (German Cancer Research Center, DE)
Dr Pernette Verschure (University of Amsterdam, NL)

Click here for the flyer and more information: http://www.epipredict.eu